SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

UPB

Upstream Bio, Inc.
NASDAQHealth Care

Latest close: 2.76 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 16, 2026Reported sale · Form 4Allison Ambrose, General Counsel · $2.7KOpen the filing ↗
  2. Sep 16, 2026Reported sale · Form 4MICHAEL GRAY, CFO and COO · $4.7KOpen the filing ↗
  3. Sep 16, 2026Reported sale · Form 4Adam Houghton, Chief Business Officer · $3.8KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record11811 flagged findings
Reported transactions (Form 4)72since Oct 10, 2024 · and 29 other holdings
Corporate events (8-K)1since Mar 26, 2026

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 118)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Insider transaction · 5 Form 4 filingsshow all 5hide
  • Sep 1, 268-K ↗Current report · Communication to the market · Other events
  • Aug 12, 26SCHEDULE 13G/A ↗Passive stake · Norges Bank · 7.7% · event on Jun 30, 26 · amendment
  • Aug 11, 2610-Q ↗Quarterly report
  • Aug 11, 268-K ↗Current report · Results
  • Jul 30, 26SCHEDULE 13G ↗Passive stake · BlackRock, Inc. · 5.2% · event on Jun 30, 26
  • Insider transaction · 11 Form 4 filingsshow all 11hide
  • Jun 10, 268-K ↗Current report · Shareholder vote results
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Decheng Capital Global Life Sciences Fund IV, L.P. · 5.0% · event on Mar 31, 26 · amendment
  • May 13, 2610-Q ↗Quarterly report
  • May 13, 268-K ↗Current report · Results

118 filings on record, the oldest from Jul 9, 24.

Listing the 25 most recent filings of the 118 on record.

8-Ks, explained

Structure1
  • Mar 26, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • FMR LLC14.8%Jun 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Norges Bank7.7%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
  • Xiangmin Cui6.1%Dec 31, 24SCHEDULE 13G ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
  • BlackRock, Inc.5.2%Jun 30, 26SCHEDULE 13G ↗
  • Decheng Capital Global Life Sciences Fund IV, L.P.5.0%Mar 31, 26SCHEDULE 13G/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
show 2 more holdershide
  • HBM Healthcare Investments (Cayman) Ltd.4.1%Sep 30, 25SCHEDULE 13G/A ↗1 earlier filing
  • TCG Crossover GP I, LLC3.9%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 16, 26Sell$3KAllison AmbroseGeneral Counsel↗
  • Sep 16, 26Sell$5KMICHAEL GRAYCFO and COO↗
  • Sep 16, 26Sell$4KAdam HoughtonChief Business Officer↗
  • Sep 16, 26Sell$12KEverett Rand SutherlandChief Executive Officer↗
  • Sep 16, 26Sell$5KAaron DeykinChief Medical Officer↗
  • Jun 16, 26Sell$3KAllison AmbroseGeneral Counsel↗
  • Jun 16, 26Sell$5KAaron DeykinChief Medical Officer↗
  • Jun 16, 26Sell$4KAdam HoughtonChief Business Officer↗
  • Jun 16, 26Sell$13KEverett Rand SutherlandChief Executive Officer↗
  • Jun 16, 26Sell$5KMICHAEL GRAYCFO and COO↗
  • Mar 16, 26Sell$6KAdam HoughtonChief Business Officer↗
  • Mar 16, 26Sell$4KAllison AmbroseGeneral Counsel↗

There are 8 more transactions in this stretch.

Stock compensation, tax and giftsshow the 12 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jan 2, 26Compensationamount n/aEverett Rand SutherlandChief Executive Officer↗
  • Jan 2, 26Compensationamount n/aAdam HoughtonChief Business Officer↗
  • Jan 2, 26Compensationamount n/aAllison AmbroseGeneral Counsel↗
  • Jan 2, 26Compensationamount n/aAaron DeykinChief Medical Officer↗
  • Jan 2, 26Compensationamount n/aMICHAEL GRAYCFO and COO↗
  • Oct 15, 24Otheramount n/aWellington Biomedical Innovation Master Investors (Cayman) II L.P.↗
  • Oct 15, 24Otheramount n/aORBIMED ADVISORS LLC↗
  • Oct 15, 24Otheramount n/aORBIMED ADVISORS LLC↗
  • Oct 15, 24Otheramount n/aErez Chimovits↗
  • Oct 15, 24Otheramount n/aErez Chimovits↗
  • Oct 15, 24Otheramount n/aAI Upstream LLC↗
  • Oct 15, 24Otheramount n/aAI Upstream LLC↗

The full record holds 32 transactions and goes back to Oct 10, 24.

Its sector and its market

Upstream Bio, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Upstream Bio, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Upstream Bio, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
118 documents on file, from Jul 9, 2024 to Sep 17, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Upstream Bio, Inc. (UPB): stock price history, insider trades and SEC filings — HornScout